INVESTMENT STRATEGY

Coastview Capital utilizes its scientific and industry experience to identify promising new drug candidates and bottlenecks in the drug discovery process.  We proactively seek companies that are working to create new product opportunities and new technologies to improve drug discovery and drug discovery processes.  We work with talented entrepreneurs to help them leverage their proprietary technologies to build the next generation biotechnology companies. 

When evaluating a company we look for the following components:

• Innovative, breakthrough science
• A top management team, able to build the right mix of science and business capabilities
• Products and technology platforms that address real pharmaceutical industry needs            
• Market and commercial potential
• A strong current or potential intellectual property position

INVESTMENT GUIDELINES

Primary Focus

• Biopharmaceutical Companies: Companies with proprietary compounds or products that have the potential to become new therapeutics
• Product Platform Companies: Companies that use proprietary technologies to discover new drug candidates for internal development and/or partnerships

Stage

Coastview invests across all stages of development, although its current focus is primarily on later stage companies.  By focusing exclusively on the life sciences sector, Coastview is able to evaluate all stages of investment opportunities and provide value-added services throughout the entire investment horizon.

Investment Size

$1-5 million initially, and up to a total of $10 million over the life of the company.

Location

Coastview considers investments in all geographical areas, depending on our investment criteria being met and the involvement of other key investors. Coastview’s preferred regions for investments are Southern California, Boston, the San Francisco Bay area, and the greater Washington D.C. area.